Skip to main content

Table 1 Factors affecting any grade oral mucositis

From: Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis

 

Number of patients (n)

Any grade mucositis (n, %)

Univariate p value

Arm

 Cisplatin

260

252 (96.9%)

1.000

 Cisplatin-nimotuzumab

264

256 (96.9%)

Gender

 Male

445

431 (96.9%)

1

 Female

79

77 (97.5%)

ECOG PS

 PS 0

116

115 (99.1%)

0.216

 PS 1–2

408

393 (96.3%)

Stage

 III

163

158 (96.9%)

1

 IV

361

350 (96.9%)

Radiotherapy technique

 Conventional

458

443 (96.7%)

0.706

 IMRT

66

65 (98.5%)

Age (continuous variable)

 Age

536

  1. ECOG-PS Eastern Cooperative Oncology Group performance score, IMRT intensity-modulated radiation therapy